What does CUSIP 921659108 represent in this 13F holders report?

CUSIP 921659108 is the security identifier for VNDA - Vanda Pharmaceuticals Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VNDA - Vanda Pharmaceuticals Inc. - Common Stock in Q2 2014?

110 institutional investors reported VNDA - Vanda Pharmaceuticals Inc. - Common Stock for Q2 2014. Use the holders table for investor-level position and value details.

Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

CUSIP: 921659108

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class: Equity / Common Stock
Shares outstanding: 59,725,905
Total 13F shares: 38,482,247
Share change: +3,318,933
Total reported value: $622,313,434
Put/Call ratio: 20%
Price per share: $16.18
Number of holders: 110
Value change: +$52,888,872
Number of buys: 60
Number of sells: 60

Quarterly Holders Quick Answers

What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2014
Previous quarter: Q1 2014

Recent filing periods for CUSIP 921659108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	7.6%	4,515,096	$73,370,000	—	31 Mar 2014	13F
BAKER BROS. ADVISORS LP	13F	Company	7.4%	4,445,696	$72,243,000	—	31 Mar 2014	13F
Palo Alto Investors LP	13F	Company	5.4%	3,215,424	$52,251,000	—	31 Mar 2014	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.9%	1,751,881	$28,468,000	—	31 Mar 2014	13F
STATE STREET CORP	13F	Company	2.6%	1,554,430	$25,262,000	—	31 Mar 2014	13F
Invesco Ltd.	13F	Company	2.5%	1,484,145	$24,118,000	—	31 Mar 2014	13F
PAULSON & CO. INC.	13F	Company	2.3%	1,392,500	$22,628,000	—	31 Mar 2014	13F
BlackRock Fund Advisors	13F	Company	2.2%	1,336,039	$21,711,000	—	31 Mar 2014	13F
Consonance Capital Management LP	13F	Company	2.1%	1,226,772	$19,935,000	—	31 Mar 2014	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	1.9%	1,153,942	$18,740,000	—	31 Mar 2014	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.8%	1,079,870	$17,548,000	—	31 Mar 2014	13F
VANGUARD GROUP INC	13F	Company	1.7%	1,002,342	$16,288,000	—	31 Mar 2014	13F
WALL STREET ASSOCIATES	13F	Company	1.2%	705,100	$11,458,000	—	31 Mar 2014	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	1%	606,489	$9,855,000	—	31 Mar 2014	13F
Bank of New York Mellon Corp	13F	Company	0.86%	512,461	$8,326,000	—	31 Mar 2014	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.84%	501,709	$8,153,000	—	31 Mar 2014	13F
ORBIMED ADVISORS LLC	13F	Company	0.77%	462,400	$7,514,000	—	31 Mar 2014	13F
NORTHERN TRUST CORP	13F	Company	0.75%	448,087	$7,281,000	—	31 Mar 2014	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.73%	433,278	$7,041,000	—	31 Mar 2014	13F
MORGAN STANLEY	13F	Company	0.62%	368,973	$5,996,000	—	31 Mar 2014	13F
DEUTSCHE BANK AG\	13F	Company	0.61%	363,846	$5,911,000	—	31 Mar 2014	13F
ALTRINSIC GLOBAL ADVISORS LLC	13F	Company	0.59%	350,000	$5,688,000	—	31 Mar 2014	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.55%	329,280	$5,351,000	—	31 Mar 2014	13F
MACQUARIE GROUP LTD	13F	Company	0.47%	280,000	$4,550,000	—	31 Mar 2014	13F
Independence Capital Asset Partners, LLC	13F	Company	0.45%	269,917	$4,386,000	—	31 Mar 2014	13F
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC	13F	Company	0.4%	240,370	$3,907,000	—	31 Mar 2014	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.38%	225,480	$3,664,000	—	31 Mar 2014	13F
D. E. Shaw & Co., Inc.	13F	Company	0.37%	220,882	$3,589,000	—	31 Mar 2014	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.36%	214,792	$3,490,000	—	31 Mar 2014	13F
THB ASSET MANAGEMENT	13F	Company	0.35%	207,900	$3,378,000	—	31 Mar 2014	13F
Hudson Bay Capital Management LP	13F	Company	0.35%	206,909	$3,362,000	—	31 Mar 2014	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.33%	200,000	$3,250,000	—	31 Mar 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.32%	189,929	$3,086,000	—	31 Mar 2014	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.32%	189,200	$3,075,000	—	31 Mar 2014	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.3%	180,017	$2,925,000	—	31 Mar 2014	13F
MARSHALL WACE, LLP	13F	Company	0.28%	170,104	$2,764,000	—	31 Mar 2014	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.24%	144,707	$2,595,000	—	31 Mar 2014	13F
Lombard Odier Asset Management (USA) Corp	13F	Company	0.25%	150,000	$2,438,000	—	31 Mar 2014	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.24%	146,148	$2,375,000	—	31 Mar 2014	13F
GROUP ONE TRADING LLC	13F	Company	0.23%	138,549	$2,251,000	—	31 Mar 2014	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.21%	126,400	$2,054,000	—	31 Mar 2014	13F
HIGHLAND CAPITAL MANAGEMENT LP	13F	Company	0.21%	123,090	$2,000,000	—	31 Mar 2014	13F
GAGNON SECURITIES LLC	13F	Company	0.19%	111,118	$1,806,000	—	31 Mar 2014	13F
SMITH ASSET MANAGEMENT GROUP LP	13F	Company	0.18%	109,874	$1,785,000	—	31 Mar 2014	13F
Iguana Healthcare Management, LLC	13F	Company	0.17%	100,000	$1,625,000	—	31 Mar 2014	13F
CREDIT AGRICOLE S A	13F	Individual	0.16%	97,226	$1,580,000	—	31 Mar 2014	13F
BlackRock Investment Management, LLC	13F	Company	0.15%	91,877	$1,493,000	—	31 Mar 2014	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.15%	91,448	$1,486,000	—	31 Mar 2014	13F
CREDIT SUISSE AG/	13F	Company	0.14%	81,667	$1,327,000	—	31 Mar 2014	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.12%	74,513	$1,211,000	—	31 Mar 2014	13F

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q2 2014

As of 30 Jun 2014, Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,482,247 shares. The largest 10 holders included FMR LLC, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, Palo Alto Investors, LLC, PAULSON & CO INC, KINGDON CAPITAL MANAGEMENT, L.L.C., Signpost Capital Advisors, LP, State Street Corp, Invesco Ltd., and BlackRock Fund Advisors. This page lists 110 institutional shareholders reporting positions in this security for the Q2 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2014 vs Q1 2014 Across Filers

Q1 2014 holders

109

Q2 2014 holders

110

Holder diff

Investor	Q1 2014 Shares	Q2 2014 Shares	Share Diff	Share Chg %	Q1 2014 Value $	Q2 2014 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.